Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2015-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2015.01.032PMID 25684421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct Interaction and Functional Coupling between Human 5-HT6 Receptor and the Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B-LC1)

  2014cited by this paper
• Synthesis and Inhibition Effects on 5-HT 6 Receptor of Benzothiazole Derivatives

  2013cited by this paper
• Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.

  2013cited by this paper
• 5-HT2 ligands in the treatment of anxiety and depression

  2012cited by this paper
• Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists.

  2012cited by this paper
• Direct condensation of sulfonamide and formamide: NaI-catalyzed synthesis of N-sulfonyl formamidine using TBHP as oxidant.

  2011cited by this paper
• 5-HT(6) receptor and cognition.

  2011cited by this paper
• Serotonin induces melanogenesis via serotonin receptor 2A

  2011cited by this paper
• Pharmacology of 5-HT6 receptors--Part 1. Preface.

  2010cited by this paper
• Therapeutic Potential of 5-HT2C Receptor Ligands

  2010cited by this paper
• 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey

  2010cited by this paper
• Synthesis and biological evaluation of (phenylpiperazinyl-propyl)arylsulfonamides as selective 5-HT(2A) receptor antagonists.

  2010cited by this paper
• New Serotonin 5-HT6 Ligands from Common Feature Pharmacophore Hypotheses

  2008cited by this paper
• Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease.

  2008cited by this paper
• Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role.

  2008cited by this paper
• HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study

  2007cited by this paper
• Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.

  2006cited by this paper
• Effects of the Serotonin Type 2A, 3A and 3B Receptor and the Serotonin Transporter Genes on Paroxetine and Fluvoxamine Efficacy and Adverse Drug Reactions in Depressed Japanese Patients

  2006cited by this paper
• A new class of selective, non-basic 5-HT2A receptor antagonists.

  2006cited by this paper
• KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.

  2005cited by this paper
• A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists.

  2005cited by this paper
• Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.

  2005cited by this paper
• 5-HT2 receptors.

  2004cited by this paper
• The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

  2004cited by this paper
• Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.

  2003cited by this paper
• Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.

  2002cited by this paper
• The neuropharmacology of serotonin and noradrenaline in depression

  2002cited by this paper
• 5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI

  2002cited by this paper
• Current and novel approaches to the drug treatment of schizophrenia.

  2001cited by this paper
• Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment

  2001cited by this paper
• Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

  2000cited by this paper
• PYBROP: A CONVENIENT ACTIVATOR FOR THE SYNTHESIS OF FORMAMIDINES

  1999cited by this paper
• Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone

  1998cited by this paper
• 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

  1998cited by this paper
• Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex

  1997cited by this paper
• Regulation of central 5-HT2A receptors: a review of in vivo studies.

  1995cited by this paper

• Recent Advances on Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids.

  2022cites this paper
• Nitrobutadienes as powerful benzannulating agents: An unprecedented easy access to rare nitroindoles

  2019cites this paper
• In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease

  2018cites this paper